Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01801358
Title A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis|Novartis Pharmaceuticals
Indications

ocular melanoma

Therapies

Binimetinib

Binimetinib + Sotrastaurin

Age Groups: adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.